logo

For the Inventor, By the Inventor

Vancouver, WA, United States of America

Cytodyn Inc.

Calculating rank
USPTO Granted Patents = 9

% Expired Patents = 44.4



Forward Citations = 30

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Daniel C Pevear (2 out of 38 patents)

silverMedal Scott Kelly (2 out of 2 patents)

bronzeMedal Paul J Maddon (2 out of 48 patents)

4.  Robert J Israel (2 out of 4 patents)

5.  Jose D Murga (2 out of 2 patents)

6.  Tracy T Chen (2 out of 2 patents)

7.  William C Olson (2 out of 88 patents)

8.  Nader Pourhassan (1 out of 1 patent)

9.  Jacob B Lalezari (1 out of 1 patent)

10.  Bruce K Patterson (1 out of 26 patents)

11.  Robert T Schooley (1 out of 3 patents)

12.  Nader Z Pourhassen (1 out of 1 patent)

13.  Richard Trauger (1 out of 2 patents)

14.  Denis R Burger (1 out of 1 patent)

15.  Denis Burger (1 out of 1 patent)


9 patents:

1. 12624111 - METHODS FOR TREATING METASTATIC COLON CANCER WITH LERONLIMAB (2026-05-12),
2. 11584797 - Inhibition of CCL5 ligand binding to CCR5 receptor and alteration of CCR5/CCL5 axis signaling in inflammation, cancer, autoimmune, and other conditions (2023-02-21),
3. 11571383 - Concentrated protein formulations and uses thereof (2023-02-07),
4. 11045546 - Methods of treating coronavirus infection (2021-06-29),
5. 10562969 - Substitution monotherapy treatment for HIV-1 infection employing antibody PRO140 (2020-02-18),
6. 10500274 - Methods for reducing viral load in HIV-1 infected patients (2019-12-10),
7. 9956165 - Concentrated protein formulations and uses thereof (2018-05-01),
8. 9499621 - Felinized antibodies and methods of treating retroviral infections in felines (2016-11-22),
9. 8821877 - Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist (2014-09-02),
Company Overview
Cytodyn Inc. is a biotechnology company focused on developing novel antibodies for the treatment of a variety of diseases. Their flagship product, leronlimab, is currently in clinical trials for HIV, COVID-19, and certain types of cancer. The company is committed to improving patient outcomes through innovative therapeutics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Cytodyn Inc. USPTO Patent Assignee Logo
9 Patents

#35 in Vancouver, WA

#757 in Washington

#32,627 in US

Vancouver, WA (US)
Vancouver, WA, United States of America

Cytodyn Inc.

Forward Citations = 30

15 inventors:

goldMedal Daniel C Pevear (2 out of 38 patents)

silverMedal Scott Kelly (2 out of 2 patents)

bronzeMedal Paul J Maddon (2 out of 48 patents)

4.  Robert J Israel (2 out of 4 patents)

5.  Jose D Murga (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytodyn Inc.. Retrieved from https://idiyas.com/company/cytodyn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…